Literature DB >> 10785411

New bisindole alkaloids of the topsentin and hamacanthin classes from the Mediterranean marine sponge Rhaphisia lacazei.

A Casapullo1, G Bifulco, I Bruno, R Riccio.   

Abstract

Chemical investigation of the Et(2)O extract of the marine sponge Rhaphisia lacazei resulted in the isolation of 13 pure bisindole alkaloids (1-13). Compounds (1-6) belong to the class of topsentins and have already been described. Compounds 7-13 are new products, closely related to the class of hamacanthins. The major compounds 1-3 were tested in vitro for antitumor activity; compounds 2 and 3 showed antiproliferative activity against human bronchopulmonary cancer cells (NSCLC-N6) with an IC(50) of 12 and 6.3 microg/mL, respectively.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10785411     DOI: 10.1021/np9903292

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  16 in total

1.  Functionalized ionic liquid-assisted chromatography-free synthesis of bis(indolyl)methanes.

Authors:  Sunita Choudhary; Khima Pandey; Saroj Budania; Anil Kumar
Journal:  Mol Divers       Date:  2017-01-11       Impact factor: 2.943

2.  Methicillin-resistant Staphylococcus aureus (MRSA) pyruvate kinase as a target for bis-indole alkaloids with antibacterial activities.

Authors:  Roya Zoraghi; Liam Worrall; Raymond H See; Wendy Strangman; Wendy L Popplewell; Huansheng Gong; Toufiek Samaai; Richard D Swayze; Sukhbir Kaur; Marija Vuckovic; B Brett Finlay; Robert C Brunham; William R McMaster; Michael T Davies-Coleman; Natalie C Strynadka; Raymond J Andersen; Neil E Reiner
Journal:  J Biol Chem       Date:  2011-10-26       Impact factor: 5.157

3.  I2-Catalyzed sulfenylation of indoles and pyrroles using triethylammonium thiolates as sulfenylating agents.

Authors:  Wei Fan; Zhen Yang; Bo Jiang; Guigen Li
Journal:  Org Chem Front       Date:  2017-02-20       Impact factor: 5.281

4.  Synthesis and antiproliferative activity of thiazolyl-bis-pyrrolo[2,3-b]pyridines and indolyl-thiazolyl-pyrrolo[2,3-c]pyridines, nortopsentin analogues.

Authors:  Anna Carbone; Barbara Parrino; Gloria Di Vita; Alessandro Attanzio; Virginia Spanò; Alessandra Montalbano; Paola Barraja; Luisa Tesoriere; Maria Antonia Livrea; Patrizia Diana; Girolamo Cirrincione
Journal:  Mar Drugs       Date:  2015-01-16       Impact factor: 5.118

5.  3-[4-(1H-indol-3-yl)-1,3-thiazol-2-yl]-1H-pyrrolo[2,3-b]pyridines, nortopsentin analogues with antiproliferative activity.

Authors:  Barbara Parrino; Anna Carbone; Gloria Di Vita; Cristina Ciancimino; Alessandro Attanzio; Virginia Spanò; Alessandra Montalbano; Paola Barraja; Luisa Tesoriere; Maria Antonia Livrea; Patrizia Diana; Girolamo Cirrincione
Journal:  Mar Drugs       Date:  2015-04-03       Impact factor: 5.118

Review 6.  Indole alkaloid marine natural products: an established source of cancer drug leads with considerable promise for the control of parasitic, neurological and other diseases.

Authors:  Waseem Gul; Mark T Hamann
Journal:  Life Sci       Date:  2005-10-19       Impact factor: 5.037

7.  Synthesis and Antitumor Activity of New Thiazole Nortopsentin Analogs.

Authors:  Virginia Spanò; Alessandro Attanzio; Stella Cascioferro; Anna Carbone; Alessandra Montalbano; Paola Barraja; Luisa Tesoriere; Girolamo Cirrincione; Patrizia Diana; Barbara Parrino
Journal:  Mar Drugs       Date:  2016-12-14       Impact factor: 5.118

Review 8.  A journey under the sea: the quest for marine anti-cancer alkaloids.

Authors:  Rita Tohme; Nadine Darwiche; Hala Gali-Muhtasib
Journal:  Molecules       Date:  2011-11-23       Impact factor: 4.411

9.  Synthesis and antiproliferative activity of 2,5-bis(3'-indolyl)pyrroles, analogues of the marine alkaloid nortopsentin.

Authors:  Anna Carbone; Barbara Parrino; Paola Barraja; Virginia Spanò; Girolamo Cirrincione; Patrizia Diana; Armin Maier; Gerhard Kelter; Heinz-Herbert Fiebig
Journal:  Mar Drugs       Date:  2013-03-01       Impact factor: 5.118

10.  Marine derived hamacanthins as lead for the development of novel PDGFRβ protein kinase inhibitors.

Authors:  Boris Pinchuk; Eugen Johannes; Sheraz Gul; Joachim Schlosser; Christoph Schaechtele; Frank Totzke; Christian Peifer
Journal:  Mar Drugs       Date:  2013-08-26       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.